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Abstract
Background: Patients suffering from depression have a high risk of relapse and readmission in the weeks following discharge
from inpatient wards. Electronic self-monitoring systems that offer patient-communication features are now available to offer
daily support to patients, but the usability, acceptability, and adherence to these systems has only been sparsely investigated.
Objective: We aim to test the usability, acceptability, adherence, and clinical outcome of a newly developed computer-based
electronic self-assessment system (the Daybuilder system) in patients suffering from depression, in the period from discharge
until commencing outpatient treatment in the Intensive Outpatient Unit for Affective Disorders.
Methods: Patients suffering from unipolar major depression that were referred from inpatient wards to an intensive outpatient
unit were included in this study before their discharge, and were followed for four weeks. User satisfaction was assessed using
semiqualitative questionnaires and the System Usability Scale (SUS). Patients were interviewed at baseline and at endpoint with
the Hamilton depression rating scale (HAM-D17), the Major Depression Inventory (MDI), and the 5-item World Health Organization
Well-Being Index (WHO-5). In this four-week period patients used the Daybuilder system to self-monitor mood, sleep, activity,
and medication adherence on a daily basis. The system displayed a graphical representation of the data that was simultaneously
displayed to patients and clinicians. Patients were phoned weekly to discuss their data entries. The primary outcomes were
usability, acceptability, and adherence to the system. The secondary outcomes were changes in: the electronically self-assessed
mood, sleep, and activity scores; and scores from the HAM-D17, MDI, and WHO-5 scales.
Results: In total, 76% of enrolled patients (34/45) completed the four-week study. Five patients were readmitted due to relapse.
The 34 patients that completed the study entered data for mood on 93.8% of the days (872/930), sleep on 89.8% of the days
(835/930), activity on 85.6% of the days (796/930), and medication on 88.0 % of the days (818/930). SUS scores were 86.2
(standard deviation [SD] 9.7) and 79% of the patients (27/34) found that the system lived up to their expectations. A significant
improvement in depression severity was found on the HAM-D17 from 18.0 (SD 6.5) to 13.3 (SD 7.3; P<.01), on the MDI from
27.1 (SD 13.1) to 22.1 (SD 12.7; P=.006), and in quality of life on the WHO-5 from 31.3 (SD 22.9) to 43.4 (SD 22.1; P<.001)
scales, but not on self-assessed mood (P=.08). Mood and sleep parameters were highly variable from day-to-day. Sleep-offset
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was significantly delayed from baseline, averaging 48 minutes (standard error 12 minutes; P<.001). Furthermore, when estimating
delay of sleep-onset (with sleep quality included in the model) during the study period, this showed a significant negative effect
on mood (P=.03)
Conclusions: The Daybuilder systems performed well technically, and patients were satisfied with the system and had high
adherence to self-assessments. The dropout rate and the gradual delay in sleep emphasize the need for continued clinical support
for these patients, especially when considering sleep guidance.
(J Med Internet Res 2017;19(4):e123)   doi:10.2196/jmir.6673
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Introduction
Major Depression
Major depression is estimated by the World Health Organization
to top the list of the 20 most financially burdensome disorders
in the Western world [1], and a substantial part of these costs
cover hospital treatment for patients with severe depression who
have long-standing admissions, and who are often readmitted
due to relapse [2,3]. Thus, in Denmark, these patients have
readmission rates between 10-30% in the months following
discharge [4]. Furthermore, there is an increased risk of suicide
in the immediate period following discharge [5]. Therefore,
new tools and treatments are needed to prevent readmission and
suicide after discharge from inpatients wards.
Electronic Monitoring
Increased access to reliable and fast Internet services and the
development of interactive systems have spurred interest in the
use of electronic monitoring in medicine [6], including
psychiatry, where electronic monitoring is increasingly being
used as a clinical tool [7,8]. Existing systems differ in mode of
function and complexity. Some systems offer interactive
self-help with psychotherapy/psychoeducation [9], some include
clinical backup, some are designed for use on smartphones, and
others are designed for computers or tablets [10]. A small
number of systems use a bidirectional feedback loop between
patients and clinicians [11,12], in which data entered by patients
can be seen in real-time by the clinician, and responses can
occur immediately if needed. These systems make it easier for
patients and clinicians to notice changes in conditions over time,
be it behavioral changes such as activity or medication, or
psychopathological symptoms (eg, mood and sleep). Using
these systems, worsening of the condition can be acted upon by
patients and clinicians in collaboration, via comonitoring [13].
In general, data entered in these systems are graphically
presented to enable patients and researchers/clinicians to
visualize relationships between the entered data and development
of the measured variables over time.
When used in research, electronic monitoring has a number of
advantages: it partly eliminates the need for pen and paper data
collection, it makes data immediately available for analyses,
and it secures day-to-day information that might otherwise be
lost due to cognitive dysfunction that is prevalent in patients
with major depression [14]. If the clinical practice can match
the opportunities given in interactive systems by supplying
feedback, patients will be enabled to make earlier adjustments
in treatment and behavior by having an earlier and more focused
response to their condition.
High dropout rates are a common problem in electronic
monitoring [15], although studies using systems that connect
patients and clinicians have higher adherence rates [16]. Some
applications have a multitude of options and can be difficult to
use for patients with depression. Simplicity and ease of use are
considered essential for users [17]. The system that we evaluated
in this study (the Daybuilder system) was developed with this
in mind, having a reduced number of assessment parameters
and a graphical representation that is central in the screen. The
Daybuilder system has been developed in close collaboration
with users and clinicians in psychiatry [18].
Summary
In summary, by using interactive electronic monitoring we can:
obtain day-to-day information of clinical state; obtain a measure
of day-to-day variability; and enable patients and clinicians to
discover time-trends and relationships between variables that
facilitate early and more focused intervention, via the graphical
representation of data over time. A pilot test with the Daybuilder
system showed the system to be easy to use and stable [18]. In
this study, the aim was to test the usability, acceptability, and
adherence to the Daybuilder system in patients suffering from
depression who were discharged from inpatient psychiatric
wards, and patients were followed for four weeks. We also
report relapse, the time courses of mood, sleep, and activity,
and the interrelatedness of these factors.
Methods
Design
The study design was a single arm observational study. The
study consisted of three distinct periods: Phase 1 was the period
from inclusion to discharge, Phase 2 was the period from
discharge to commencing treatment at the Intensive Outpatient
Unit for Affective Disorders (IOA) service, and Phase 3 was
the period from the start at IOA to the end of each patient's
four-week study period.
Participants
Patients suffering from unipolar major depression that were
referred from inpatient wards to an IOA were asked to
participate in the study before they were discharged from
psychiatric inpatient wards. The scientific ethical committee
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for the Capital Region of Copenhagen was informed about the
study in writing (Journal nr. H-3-2013-FSP32) and decided that
the study did not require review by the committee. The study
was approved by Psychiatric Center Copenhagen and the Danish
Data Agency (RHP-2013-023, I-Suite number: 02470). The
patient identification list was kept under double lock. Baseline
procedures consisted of a psychometric assessment and an
introduction to the Daybuilder system. Informed consent was
obtained from all participants after oral and written information
had been given about the study content and possible
consequences.
Eligibility Criteria
Inclusion criteria included: major depression as defined in the
Diagnostic and Statistical Manual of Mental Disorders 4thedition,
and age >18 years. Exclusion criteria included: suicidality
(corresponding to a score of 2 or above on the Hamilton
depression rating scale [HAM-D17] item 3, or if the investigators
were unable to assess the degree of suicidality), abuse of alcohol
or other substances that could influence the use of the
Daybuilder system, bipolar illness, psychotic depression for the
last two weeks prior to inclusion, and comorbid dementia or
other organic brain damage that could influence the participant’s
ability to use the Daybuilder system. Criteria for leaving the
study included: patients wishing to leave the study or admittance
for a somatic illness that would potentially influence the ability
to use the Daybuilder system. Patients were allowed to continue
in the study if readmitted to an inpatient psychiatric ward.
Psychometric Assessment
Sociodemographics were collected through interviews and from
case files. Diagnostic confirmation was done by use of the
Mini-International Neuropsychiatric Interview instrument [19].
Baseline and endpoint depression severity were assessed by the
investigator-administered HAM-D17 scale [20] which covers
the full spectrum of depression symptoms, the Hamilton six-item
subscale (HAM-D6) [21] which covers the core symptoms of
depression, the Bech-Rafaelsen melancholia scale (MES) which
includes items covering symptoms of psychomotor retardation
[22], and paper-and-pen self-assessment was done with the
Major Depression Inventory (MDI) [23], and the 5-item World
Health Organization Well-Being Index (WHO-5) scale [24].
Patients answered semiqualitative questions regarding the
usability of the system at baseline and at the endpoint. These
questions covered expectations on the use of the system at
inclusion, and reflection on experiences with the system at the
endpoint. Patients were asked to fill in the System Usability
Scale (SUS) at endpoint [25].
Daybuilder Procedures
A patient-specific profile was created on the Daybuilder
webpage for each patient, and each person was assigned a study
number and an email address to enable them to log into the
system. Patients were instructed on how to use Daybuilder, and
how to enter the following variables on all days of the four-week
study period: sleep-onset, sleep-offset, number of awakenings
at night, quality of sleep, naps (time and duration), mood
(morning and evening), activity (number of minutes outside the
psychiatric ward, or when discharged as minutes outside their
home as an estimate of activity), and medication (whether daily
medication were taken or not). Mood and quality of sleep were
entered on a Visual Analog Scale (VAS; 0=worst
depression/worst sleep ever; 10=no depression/best sleep).
Participants were instructed to enter mood scores in the morning
and evening. Patients began data entry in the Daybuilder system
on the day of inclusion. Study investigators phoned patients
weekly to aid with any problems related to Daybuilder and to
discuss outcomes of data monitoring, as seen in the Daybuilder
graphs. Patients were seen by investigators at a final visit after
four weeks. Text messages were used during the project to help
patients remember that they had to enter their data. Patients’
data were not seen between telephone calls.
All entries into the Daybuilder system were done through the
computer (personal computer or Mac), except mood values
which could also be entered through short message service
(SMS) text messaging. A reminder was sent twice daily over
SMS texting to register mood. When entering values in
Daybuilder, the system automatically generated a graphic display
of all variables to aid understanding of evolving patterns and
relationships between variables (eg, between mood, sleep, and
activity; see Figure 1).
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Figure 1. An example of graphic presentation in the Daybuilder application for sleep, mood, and exercise.
Outcomes
The primary outcomes were usability, acceptability, and
adherence, which were assessed by SUS scores, semiqualitative
questions, and adherence to data entry in the electronic system.
Secondary outcomes were changes in self-assessed daily scores
of mood, sleep, activity, and medication adherence.
Statistics
Usability, acceptability, and adherence measures were analyzed
on completers, who were defined as patients clinically assessed
at endpoint visit. Adherence was calculated as a percentage of
data entry days in relation to the planned four-week study period,
for each data entry parameter (eg, sleep, mood). Mood, sleep,
and activity outcomes were analyzed using available data from
all included patients. A mean daily mood score was calculated
for those with more than one mood entry per day. Correlation
between Hamilton scores and mood scores was calculated using
the Pearson correlation procedure.
Daily continuous scale scores that were entered, including sleep
scores, were analyzed in a random linear regression model using
available data from all included patients with intercept and day
as random effects. Results are given as estimated values,
confidence limits (CLs), standard errors (SEs), and P-values.
For explorative analyses on sleep parameters, the model only
included time (day) as a covariate. For explorative analyses on
mood the model included time (day), sleep-onset, sleep-offset,
sleep quality, activity, and interactions between sleep-onset and
day, sleep-offset and day, sleep quality and day, and activity
and day. Summary means for sociodemographics, usability,
adherence, and acceptability measures are given with standard
deviations (SDs). All time points are in the form of
hour:minutes.
Based on the paper by Bech et al [26] showing that when
comparing MDI depression scores with a VAS scale (0=no
depression; 100=worst depression), the cut-off for severe
depression on the MDI (scores 31-50, higher scores indicating
worse depression) corresponded to a VAS score of 58.4
(MDI=0.49*VAS+2.4). The VAS score used in this study was
reversed with 0 as the worst score and 10 as the best, so we
translated the VAS score of 58.4 (approximated to 60) to a score
of 4 and below as a signifier of severe depression. The level of
statistical significance was set at 5%, and was two-sided.
Analyses were performed by SAS software (SAS system for
Windows, release 9.4., SAS Inst., Cary, NC, USA).
Results
Participants
In total, 230 patients were referred to the IOA in the inclusion
period from September 2013 to March 2015. Only 89 patients
were asked to participate, as the remaining did not fulfill
inclusion criteria or fulfilled exclusion criteria, or were already
discharged at the time of screening. A total of 45 patients
accepted the invitation to join the study. Sociodemographic data
is detailed in Table 1.
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Table 1. Sociodemographic data.
% or mean (SD)Sociodemographics
55.6%Gender, females
35.9 (10.8)Age, years
10.2 (11.7)Duration of current episode, months
2.5 (5.7)Number of previous episodes
73.3%Sick leave in current episode
8.9%Suicide attempt in current episode
84.4%Number of patients with a self-perceived eliciting factor for actual episode
22.2%Smoking
22.2%Electro Convulsive Treatment in current episode
8.1 (15.6)Alcohol consumption, number of drinks per month
Mean age was 35.9 years (SD 10.8). Patients had 2.5 previous
episodes of major depression (SD 5.7) and a mean duration of
current depression of 10.2 months (SD 11.7). Most patients
were on sick leave. Only a few patients had attempted suicide
in the current episode before admission. Patients were treated
with 1.9 drugs (SD 0.9; range 0-4): antidepressants included
Selective Serotonin Reuptake Inhibitors (n=12),
Serotonin-Norepinephrine Reuptake Inhibitors (n=15),
Noradrenergic and Specific Serotonergic Antidepressants
(n=11), mianserin (n=11), Tricyclic Antidepressants (n=15),
isocarboxazid (n=1), and agomelatine (n=1); antipsychotics
included quetiapine (n=8) and olanzapine (n=2); mood
stabilizers included lithium (n=5) and lamotrigine (n=4);
benzodiazepines (n=3); hypnotics (n=3); and melatonin (n=2).
Usability, Acceptability, and Adherence
In total, 76% of enrolled patients (34/45) completed the
four-week study; six patients dropped out during study Phase
1, and five patients during study Phase 2. The causes of dropout
included worsening of depression for six patients, and
miscellaneous nonillness related issues for the remaining five
patients. An additional five patients were readmitted to an
inpatient ward due to worsening of depression (all in study
Phase 2), all of whom continued their self-monitoring and were
evaluated at endpoint. Six patients were not discharged on the
last day of data entry. Thus, the readmission rate was 13%
(5/39). Mean days in study Phase 1 was 6.4 (7.9; range 0-28),
study Phase 2 was 7.6 (7.1; range 0-26), and study Phase 3 was
9.9 (9.6; range 0-28; P=.14). Electro Convulsive Treatment
(ECT) had been used for 22% (10/45) of all patients, 36% (4/11)
of the dropouts, and 18% (6/34) of the completers (P=.23).
Patients who dropped out entered data into Daybuilder for 12.5
days (11.9; range 1-28).
In general, patients found that the Daybuilder system lived up
to their expectations; however, when evaluated at endpoint,
patients found that they had registered less data than they had
anticipated at baseline (Table 2). Fifty-nine percent of patients
(20/34) believed that the system could detect a relapse, and 50%
of patients (17/34) believed that the system could influence the
course of their illness.
Other semiqualitative questions at baseline showed that patients
expected the Daybuilder system to enable visualization of their
condition, give support and structure, enable positive
expectations, or give a hope of recovery. Several additional
self-monitoring items were suggested, such as social activity,
appetite, meals, anxiety, cognitive function, medication, and
side effects. At endpoint, only 50% of patients (17/34) felt that
the system had covered their needs for self-monitoring. A total
of 33 patients filled in the SUS scale, with a mean value of 86.2
(SD 9.7; range 65-100). Patients not receiving ECT (n=27) had
an SUS score of 86.9 (8.9; range 65-100) and patients receiving
ECT (n=6) had a score of 82.9 (13.0; range 65-97.5; P=.40).
The importance of the weekly phone calls was rated on a scale
from 0 to 10 (10=highest importance): 58% of patients (19/33)
rated in the interval 8-10, 33% (11/33) in the interval 5-7, and
only 9% (3/33) in the interval 0-4. The frequency of phone calls
was deemed appropriate by 35% of the patients (12/34).
Twenty-six percent of patients (9/34) would have liked more
frequent phone calls or a combination of consultation and
telephone contact, 12% (4/34) suggested being contacted when
the Daybuilder registrations showed signs of deterioration or if
data entry was missing, 9% (3/34) felt a need for a more flexible
and individualized design that would depend on their mental
state, and 18% (6/34) did not answer this question.
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Table 2. Usability data from semiqualitative questions asked at baseline and endpoint.
Endpoint, %
(n=34)
Baseline,
% (n=43)
Theme
Did the Daybuilder system live up to expectations?
79 (27)Yes
12 (4)No
9 (3)Uncertain
0 (0)No response
Do you think you will be able to make all registrations/did you make all registrations?
74 (25)98 (42)Yes
26 (9)0 (0)No
0 (0)0 (0)Uncertain
0 (0)2 (1)No response
Do you expect that self-monitoring of mood will influence your mood/did self-monitoring influence
your mood?
32 (11)44 (19)Yes
65 (22)37 (16)No
0 (0)19 (8)Uncertain
3 (1)0 (0)No response
Is the need for self-monitoring covered in the Daybuilder system?
50 (17)53 (23)Yes
41 (14)30 (13)No
0 (0)12 (5)Uncertain
9 (3)5 (2)No response
Do you expect that the Daybuilder system can detect/did detect a relapse of depression?
59 (20)65 (28)Yes
18 (6)2 (1)No
18 (6)30 (13)Uncertain
6 (2)2 (1)No response
Do you expect that the Daybuilder system will influence the course of your illness/did the system
influence the course of your illness?
50 (17)56 (24)Yes
47 (16)35 (15)No
0 (0)2 (1)Uncertain
3 (1)7 (3)No response
Only 9% of patients (3/34) were worried about technical
problems and 79% of patients (27/34) found that the system
lived up to their expectations. Thirty-two percent of patients
(11/34) felt that their self-assessment of mood in the Daybuilder
system had influenced their mood, but only one patient felt that
it had a negative effect. Adherence with data entry into the
Daybuilder application for the 34 completers was high: mood
on 93.8% of the days (872/930), sleep on 89.8% of the days
(835/930), activity on 85.6% of the days (796/930), and
medication on 88.0% of the days (818/930).
Mood, Sleep, and Activity Outcomes From the
Daybuilder System
Table 3 details the self-assessment scores from the Daybuilder
system. Self-assessed mood was not significantly improved
during the four-week study period (P=.08). Additional analyses
showed that the frequency of mood scores <4 (equivalent to
severe depression), were prevalent in all three phases: 44% in
Phase 1, 31% in Phase 2, and 32% in Phase 3. Figure 2 shows
each patient’s self-assessed mood scores from the Daybuilder
system, with day of discharge inserted (marked DS in the figure),
and illustrates the high day-to-day variability. Inspection of the
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patients that were readmitted showed no substantial worsening of mood prior to readmission.
Table 3. Estimated self-assessment scores from the Daybuilder system.
Activity minutes
(SE)
Sleep Quality score
(SE)
Sleep-midpoint hh:mm
(SE, min)
Sleep-offset hh:mm
(SE, min)
Sleep-onset hh:mm
(SE, min)
Mood score
(SE)
Day
156.9 (17.6)5.2 (0.2)3:36 (8)7:42 (9)23:30 (9)4.7 (0.3)Day 1
168.6 (15.0)5.4 (0.2)3:46 (8)7:54 (9)23:38 (9)4.9 (0.2)Day 8
180.2 (15.2)5.6 (0.2)3:56 (10)8:07 (10)23:46 (10)5.0 (0.3)Day 15
191.9 (18.0)5.8 (0.2)4:07 (11)8:19 (12)23:53 (15)5.1 (0.3)Day 22
201.9 (21.8)5.9 (0.3)4:15 (13)8:30 (14)24:00 (14)5.3 (0.3)Day 28
45.1 (25.6)0.7 (0.3)00:39 (10)00:48 (12)00:29 (10)0.5 (0.3)Change
.09.04<.001<.001.006.08P-value
Sleep-offset at endpoint was delayed to 48 minutes (SE 12)
compared to baseline sleep-offset (P<.001; t=4.0, CL 24.6-74.7)
and was mostly prevalent in Phase 2. The range of sleep-onset
was from 19:00 to 06:30, and sleep-offset was from 24:00 to
14:30. should be " Sleep duration was 8:12 (hours:minutes) at
baseline and 8:30 (hours:minutes) at endpoint (P=.10). Sleep
quality was significantly improved during the four-week period
from 5.2 (SE 0.2) to 5.9 (SE 0.3; P=.04; t=2.2; CL 0.05-1.4).
Naps were only taken on 6% of study days (56/931). The mean
number of awakenings was 1.1 (1.9; range 0-20) per night.
The mean duration of activity was 156.9 minutes at baseline
(SE 17.6) and 201.9 minutes at endpoint (SE 21.8; P=.09).
Explorative analyses on the effect of sleep parameter on
self-reported mood showed no significant effect for sleep-onset,
sleep-midpoint, or sleep-offset, but sleep quality was
significantly positively associated with mood (parameter
estimate 0.15, P<.001, t=6.9; CL 0.11-0.19). Furthermore, when
estimating delay of sleep-onset (with sleep quality included in
the model) during the study period, this showed a significant
negative effect on mood (combined effect of sleep-onset and
the interaction between sleep-onset and day). Thus, a three-hour
delay in sleep-onset reduced mood by 0.4 pointscompared to
no delay (SE 0.2; P=.03; t=2.2; CL 0.04-0.77). Explorative
analyses showed no influence of study phase on self-monitored
mood and sleep quality (P=.93).
Interview and Self-Assessment Scores From
Paper-and-Pen Questionnaires
During the study period, a statistically significant reduction in
the degree of depression was seen on all depressions scales, and
an increase in scores was observed on the WHO-5 quality of
life scale (Table 4). Correlation between HAM-D17 and
self-reported mood was 0.51 (P<.001) at baseline, and 0.44
(P=.02) at endpoint. Linear regression showed a negative impact
of HAM-D17 baseline scores on adherence to sleep and mood
registrations (sleep parameters, R2=0.18, P=.01; mood scores
R2=0.10, P=.07).
Table 4. Scores from depression and quality of life scales.
P-valueEndpoint n (SD)Baseline n (SD)Scale (n)
<.00113.3 (7.3)18.0 (6.5)Hamilton Depression Rating Scale 17 item version (34)
<.0017.1 (3.7)9.9 (3.0)Hamilton Depression Rating Scale 6 item version (34)
<.00113.3 (7.0)17.9 (5.7)Bech-Rafaelsen Melancholia Scale (34)
.00622.2 (12.7)27.1 (13.1)Major Depression Inventory (33)
<.00143.4 (22.1)31.3 (22.9)5-item World Health Organization Well-Being Index (32)
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Figure 2. Individual daily self-assessed mood scores with day of discharge (DS) inserted.
Discussion
We expected the Daybuilder system to be manageable for this
patient category, and that there would be great day-to-day
variability in mood and sleep; both of these expectations were
confirmed. Based on prior results [11] we expected that a subset
of patients would feel that assessment of mood would worsen
their mood. However, this was not the case in our study, as only
one patient had this experience.
Principal Results
Based on user reviews, the usability, acceptability, and
adherence of the Daybuilder system were found to be good.
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Sleep onset and offset varied greatly from day-to-day, and the
sleep-wake cycle was delayed significantly from baseline to
endpoint. Subjective mood scores entered in the Daybuilder
system also varied greatly from day-to-day, and demonstrated
no improvement from baseline to endpoint.
Considering the short study period, a dropout rate of 24%
(11/45) in a four-week study period must be considered as large,
and was mainly caused by worsening of depression, although
the present study did not reveal the exact causes for terminating
self-monitoring. Due to IOA’s referral rules, this patient group
is expected to be more severely depressed and unstable than the
typical inpatient with depression, and from this background
some dropout is to be expected. Development in this area should
focus on mechanisms that will keep patients from dropping out,
especially when experiencing a deterioration of mood. This goal
could be accomplished by implementing alarm systems activated
at mood drops, or when assessments are missing for more than
one day.
The secondary outcomes showed that patients’ sleep drifted to
later in the day after discharge, and that this drift was associated
with worsening of mood. This finding, along with high
readmittance rates, calls for an improved system with clinician
responses based on visual inspection of daily assessments. The
results from this study have prompted us to develop a
randomized study that focuses on mood scores and also aims
to prevent sleep drift by observing sleep data on a daily basis,
and contacting patients in cases of sleep drift or sleep
irregularity.
Limitations
Patients referred to IOA probably belong to a more severely
depressed subset of inpatients, and thus do not reflect the general
group of inpatients with depression. We do not believe that the
inclusion and exclusion criteria had any major impact on patients
that were included into the study. The most common reason for
noninclusion was due to patients being discharged before we
could inform them of the project.
The study design, with a single arm, fails to determine the effects
that the Daybuilder system has on depression. This information
would require a randomized controlled trial. We cannot know
from our data whether an active clinician intervention could
have prevented dropout and readmission. This approach would
require incorporation of timely and active clinician help, and
necessitate that patient data is coupled with an automatic system
that alerts clinicians when deterioration is detected, and/or that
clinicians view patient data daily. Due to the low sample size,
negative results could easily be due to lack of power and
randomized studies in this field should include far larger sample
sizes. Conversely, we cannot rule out spurious positive findings.
ECT treatment is associated with a clinically recognizable
retrograde and anterograde amnesia, but this did not seem to
influence the use of the Daybuilder system in a significant way.
This finding is possibly a tribute to the user-friendliness of the
Daybuilder system. The present study design did not allow
clinicians to access any day-to-day assessment of patients’ data,
meaning that a worsening of patients’ conditions could only be
detected once a week, in relation to the planned telephone
consultation. This limitation puts the need for clinical
intervention into perspective.
Patients were instructed to enter morning and evening mood
scores to assess diurnal variation. However, not all patients
succeeded in this; thus, mood data reflects different time points
(morning or evening) and some of the day-to-day variation is
probably caused by diurnal variation. The registered difficulty
in entering a mood score more than once per day is probably
due to the way that mood data was entered into the Daybuilder
system, which used tabs inside the user interface. Caution should
also be taken when interpreting mean mood scores, as patients
who dropped out most likely experienced a deterioration of
mood, thus inducing a bias.
The low correlation between self-assessed mood and HAM-D17
scores at baseline (0.51; P<.001) and endpoint (0.44; P=.02)
points to patients reporting aspects of their illness with a
different content than the items covered by the Hamilton score.
Postpublication analyses from our earlier study, using a similar
depression VAS scale (Preskorn) also showed a low correlation
(Spearman) of 0.51 (P<.001) with HAM-D17 scores [27].
However, this finding does not imply that self-assessed mood
scores are less valuable than the Hamilton scores, but only that
self-assessed scores report other aspects of the depressive illness
(such as negative and positive affect), and are possibly more
akin to a patient’s own experiences of their condition. We must
also consider whether a higher daily mood sampling frequency
would be better to track mood fluctuation.
The results from sleep scores confirm that patients with
depression had a dysregulated sleep-wake cycle, with large
day-to-day variations and a substantial delay in sleep timing
when discharged. The finding that a delay in sleep-onset had a
negative impact on mood points to the possibility that an
intervention to prevent sleep delay could improve mood and
theoretically prevent relapse.
It was a surprise that patients’ self-assessed mood scores did
not significantly deteriorate in the days after discharge. It was
also unexpected that the self-assessed mood scores for those
that were readmitted did not deteriorate in the days preceding
readmission. These two results call for speculation on whether
the mood assessment that was used should be supplemented
with assessments more aimed at patient security, such as
monitoring of suicidal ideation or by using depression scales.
This consideration has prompted us to change our upcoming
study, which also uses electronic self-monitoring, such that the
wording of self-assessed mood is replaced by self-assessed
depression severity. Through communication with the patients,
we will aim at a common understanding of the word depression.
The Daybuilder system could be improved if it is developed as
an app for smartphones or tablets. This progression would
eliminate the need for patients to be near a computer, and make
data entry more flexible.
Conclusions
In conclusion, patients were satisfied with the Daybuilder system
and study completers had a high adherence to the Daybuilder
application. The dropout rate and the gradual delay in sleep
emphasize the need for continued clinical support for patients
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discharged from psychiatric wards, especially concerning sleep
guidance.
Improvement of the current Daybuilder system could be done
using daily clinician monitoring and daily responses to data
entry. This approach could be restricted to patients with
suspected suicidal risk or high risk of relapse, such as patients
treated with ECT [28]. Additionally, alarms connected to mood
ratings could be incorporated into the software to alert clinicians
to patients that are deterioration or not registering data. Other
improvements include: development of a smartphone app, the
use of chat systems, and SMS options to facilitate
communication between patients and clinicians. Such an
improved full version would add to patient empowerment and
autonomy [29,30]. The present study, focusing on usability,
highlights the need for interaction between the clinician and the
patient.
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